Pfizer, Moderna vaccines likely to provide lasting immunity, Washington University study finds

The Moderna and Pfizer vaccines will likely provide lasting immunity to Covid-19, according to findings from a new study by the Washington University School of Medicine in St. Louis. Both vaccines were authorized for emergency use and employed mRNA technology, which has never been used before in FDA-approved vaccines. Both vaccines performed well in clinical trials, and both have been widely credited with reducing disease, but there have been concerns over how long immunity in duced by the new vaccine…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news